HEALTH● LOWAug 31 · Aug 31, 2026, 9:07 AM
Amgen's Repatha cuts death risk by 20% in heart study
Seeking Alpha Tech · global
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH54m agoEdwards Lifesciences says PASCAL beats medical therapy for tricuspid repairSeeking Alpha TechHEALTH56m agoFitness program cut transplant waitlist death risk by half, study findsThe HillHEALTH1h agoUS dairy worker dies from bird flu as outbreak rages in cattleThe TelegraphHEALTH2h agoHealth Review: Ebola case, child malnutrition, medicine security, other developments that shaped OctoberPremium Times